Saphnelo
Payments companies reported to CMS as associated with Saphnelo. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Saphnelo, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Saphnelo
These are the largest totals companies reported as associated with Saphnelo. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Dinesh Khanna | Ann Arbor, MI | Rheumatology | $333,783.38 |
| Andrew Sulich | Saint Clair Shores, MI | Rheumatology | $324,860.40 |
| Sudhakar Tumuluri | San Francisco, CA | Rheumatology | $311,528.74 |
| Gordon Lam | Charlotte, NC | Rheumatology | $226,842.89 |
| Sanjay Chabra | El Paso, TX | Rheumatology | $186,860.15 |
| Frank Wellborne | New Braunfels, TX | Rheumatology | $177,337.23 |
| Marilyn Pike | Boston, MA | Rheumatology | $148,171.33 |
| Leonard Calabrese | Cleveland, OH | Rheumatology | $142,668.05 |
| Asim Khan | Maple Grove, MN | Rheumatology | $131,924.29 |
| Pendleton Wickersham | San Antonio, TX | Rheumatology | $124,558.20 |
Prescribed Saphnelo?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.